Dr. Erminia Massarelli, MD
Claim this profileCity of Hope Comprehensive Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
12 reported clinical trials
18 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
PD-L1 positive
2Non-Small Cell Lung Cancer
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Erminia Massarelli, MD is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
INBRX-106 + Pembrolizumab
for Lung Cancer
This is a Phase 1/2, open-label, non-randomized, 4-part trial to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of INBRX 106 administered as a single agent or in combination with the anti-PD-1 checkpoint inhibitor (CPI) pembrolizumab (Keytruda®). KEYTRUDA is a registered trademark of Merck Sharp \& Dohme LLC, a subsidiary of Merck \& Co., Inc., Rahway, NJ, USA.
Recruiting1 award Phase 1 & 25 criteria
More about Erminia Massarelli, MD
Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Erminia Massarelli, MD has experience with
- ISA101b
- Cemiplimab
- Pembrolizumab
- Minnelide
- Osimertinib
- CISH Inactivated TIL
Breakdown of trials Erminia Massarelli, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Thyroid Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erminia Massarelli, MD specialize in?
Erminia Massarelli, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Erminia Massarelli, MD currently recruiting for clinical trials?
Yes, Erminia Massarelli, MD is currently recruiting for 3 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Erminia Massarelli, MD has studied deeply?
Yes, Erminia Massarelli, MD has studied treatments such as ISA101b, Cemiplimab, Pembrolizumab.
What is the best way to schedule an appointment with Erminia Massarelli, MD?
Apply for one of the trials that Erminia Massarelli, MD is conducting.
What is the office address of Erminia Massarelli, MD?
The office of Erminia Massarelli, MD is located at: City of Hope Comprehensive Cancer Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.